GENERAL COMMENTS
The project presented by the authors is a very original and interesting project aiming to assess the "acceptability" of using PDX for patients with and without cancer and also parents of patients. The idea is nice, but the current paper does not present any result.
Major concern:
The paper just present a research protocol with the methods that will be used. I beleive that the paper will only be ready for publication when it will include the results and the discussion of these results
Other major comments: 1) in methods, measures: the investigators will exclude participants who do not understand the key element of the process. This is a very serious bias. The population will not reflect a real population of patients but only those who are able to understand PDX. This indicate that only patients who understand the use of PDX may benefit of it. This is wrong: it will prevent the generalisation of the data. We do not exclude patients from treatments or investigations or molecular test if they do not understand them.
2) The maximum out-of-pocket cost accepted by the patients will highly vary baised on their income 3) The questions to the patients will be asked by various investigators. How is the reproductivity of the questions and discussion be ensured?
Minor comment:
1) Investigators will adjust for multiple testing: which method?
VERSION 1 -AUTHOR RESPONSE
Reviewer 1:
This is an excellent protocol based manuscript
No response needed.
Reviewer 2:
The project presented by the authors is a very original and interesting project aiming to assess the "acceptability" of using PDX for patients with and without cancer and also parents of patients.
Major concern:
The idea is nice, but the current paper does not present any result. The paper just present a research protocol with the methods that will be used. I believe that the paper will only be ready for publication when it will include the results and the discussion of these results
We thank the Editor for not taking these comments into account given that this is a protocol paper. We have not taken any action in response to this.
Other major comments:
In methods, measures: the investigators will exclude participants who do not understand the key element of the process. This is a very serious bias. The population will not reflect a real population of patients but only those who are able to understand PDX. This indicate that only patients who understand the use of PDX may benefit of it. This is wrong: it will prevent the generalisation of the data. We do not exclude patients from treatments or investigations or molecular test if they do not understand them.
We are grateful to the reviewer for raising this important point. We recognize that it was the Editor's concern about "the potential sample bias and limited generalization of the results" which also seemed to be the key factor in rejecting the manuscript. We would like to clarify that we are collecting data from all groups of participants, including those who indicate that they do not understand PDXs. In light of the reviewer's and Editor's concern, we would like to add some additional text to the 'data analysis' section of the manuscript. This new text would further clarify that we are collecting data from all participants (whether or not they understand PDXs) and would describe our plans to conduct a subgroup analysis for those participants who indicate that they do not understand. In our experience from collecting our pilot data and the data collected to date, we expect this to be a very small sample (2%). We would be pleased to have the opportunity to add the following text to the manuscript:
'If participants indicate that they do not understand the PDX description we will conduct a subgroup analysis of the data from this group to examine their acceptance and willingness to use PDXs. We anticipate this number to be low (~2%) based on our pilot data. The exact statistical tests for this analysis will therefore depend on the final number of participants who indicate that they do not understand the description.' (page 13)
2) The maximum out-of-pocket cost accepted by the patients will highly vary biased on their income
We agree with the reviewer that income will be an important indicator of participants' willingness-to-pay. We hypothesize that higher income participants will be willing to pay more for PDX and we plan to analysis this specific relationship, which is already described in the 'data analysis' section:
'The regressions will test the influence of key sociodemographic factors including: the target patient (i.e. considering PDX for themselves or for their child), sex, income and education.' (page 13)
3) The questions to the patients will be asked by various investigators. How is the reproductivity of the questions and discussion be ensured?
The reviewer raises an important point and is an issue that we have considered in the study. We will compare adherence to the interview schedule alongside data collection and any data with interviewers who deviate >15% from the standard schedule will be excluded from analysis to maximize reproducibility. However, given the highly structured interview schedule and standardized questions/responses, we expect that there will be little variance between interviewers. This is supported by our experience collecting data and monitoring consistency to date, as well as during data collection in our pilot study. We would be willing to add the following to the 'data analysis' section of the manuscript:
'We will check the consistency of qualitative data collection across interviewers by checking adherence to the structured interview schedule alongside data collection. Data with more than 15% deviation from the standardized interview schedule will be excluded from analysis. ' (pages 13-14) Minor comment: 1) Investigators will adjust for multiple testing: which method?
We thank the reviewer for highlighting this. We would be delighted to add the following to the methods:
"Results will be considered statistically significant when p<. 05 (two-tailed) , appropriately adjusted for multiple testing using a Bonferroni correction." (page 13) 
